🎗️ OncologyCapsule
Brukinsa
Zanubrutinib
Second-generation BTK inhibitor for B-cell malignancies including CLL, SLL, and mantle cell lymphoma.
Form
Capsule
Uses
4
Side effects
5
Category
Oncology
01
What is Brukinsa used for?
- Chronic lymphocytic leukemia (CLL)
- Small lymphocytic lymphoma (SLL)
- Waldenström macroglobulinemia
- Mantle cell lymphoma
02
Zanubrutinib side effects
Common side effects of Zanubrutinib include:
Neutropenia
Infection
Hemorrhage
Atrial fibrillation
Thrombocytopenia
CommonModerateLess common
03
Zanubrutinib warnings & precautions
- Hemorrhage risk
- Atrial fibrillation and flutter risk
- Serious infections. Monitor for fever
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Brukinsa in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.